![Yoshinori Oikawa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yoshinori Oikawa
Président chez
MyBiotics Pharma Ltd.
Health Technology
Profil
Yoshinori Oikawa currently works at MyBiotics Pharma Ltd., as Executive Chairman and Emendo Biotherapeutics, Inc., as Director.
Postes actifs de Yoshinori Oikawa
| Sociétés | Poste | Début |
|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Directeur/Membre du Conseil | - |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Health Technology |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
Choisissez Zonebourse 
